Pimagedine inhibitor of the formation of advanced glycosylation end products: Began a Phase III trial in 990 patients, with partner Marion Merrell Dow to test f

Alteon Inc. (ALTN), Ramsey, N.J.

Read the full 50 word article

How to gain access

Continue reading with a
two-week free trial.